Thursday, April 06, 2023 1:21:49 AM
"The board recognizes and appreciates James Kinley's contributions and dedication in his role as CFO over the past four years and we wish him well in the future," said Harry Bloomfield, Chairman of the Miraculins board.
https://www.accesswire.com/435700/Miraculins-Announces-the-Appointment-of-Chris-Carmichael-as-Chief-Financial-Officer
Muraculincs changes to Luminor Medical Technologies.
https://www.newsfilecorp.com/release/33402/Luminor-Medical-Technologies-Changes-Its-Name-to-RISE-Life-Science-Corp.
Luminor Medical Technologies Changes Its Name to RISE Life Science Corp.
"Mr. Bloomfield's insights during his tenure as Chairman, helped to significantly move the company forward." said Anton Mattadeen. "We wish to thank him for his leadership."
Britannia Completes "Go Public" Transaction via Reverse Takeover of Rise Life Sciences and Launches Britannia Life Sciences Inc.
https://www.newswire.ca/news-releases/britannia-completes-go-public-transaction-via-reverse-takeover-of-rise-life-sciences-and-launches-britannia-life-sciences-inc--890705573.html
Miraculins to Luminor to Rise to Britannia
Full Stop
Algernon Pharmaceuticals Announces Appointment of Harry Bloomfield, QC. as a New Board Director and Chairman
September 9, 2021
“The Company welcomes Harry Bloomfield as its newest Board member and Chairman,” said Christopher J. Moreau, CEO of Algernon Pharmaceuticals. “His extensive background and years of experience in senior business roles will be a tremendous asset to the Company as it moves forward executing its exciting and unique drug repurposing business plan.”
https://finance.yahoo.com/news/algernon-pharmaceuticals-announces-appointment-harry-110000362.html
Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) has appointed James Kinley as its chief financial officer, effective December 1, 2021.
Kinley will report to CEO Christopher Moreau, according to a statement.
"James Kinley brings significant functional expertise and technical knowledge to the company in all aspects of corporate finance, financial planning and accounting,” said Moreau.
https://www.proactiveinvestors.com/companies/news/967761/algernon-pharmaceuticals-appoints-former-medicure-financial-chief-james-kinley-as-cfo-967761.html
Leadership @ Algernon Pharmaceuticals Inc.
Harry Bloomfield, Board of Directors, Chairman
Christopher J. Moreau, CEO
James Kinley, CFO
Three Headed Monster In Black & White
The Devil Is In The Details...
And It's Headed For The Trips (.0001)
Hav @ it
M$
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM